statistiche ricercatore

Continente	#
NA - Nord America	891
AS - Asia	590
EU - Europa	415
SA - Sud America	71
AF - Africa	22
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
Totale	1.994

Nazione	#
US - Stati Uniti d'America	857
SG - Singapore	205
IT - Italia	137
CN - Cina	127
VN - Vietnam	61
BR - Brasile	55
BD - Bangladesh	43
SE - Svezia	43
HK - Hong Kong	40
DE - Germania	34
KR - Corea	34
FR - Francia	31
FI - Finlandia	25
NL - Olanda	25
UA - Ucraina	21
RU - Federazione Russa	19
BG - Bulgaria	16
GB - Regno Unito	16
PL - Polonia	16
IN - India	15
TR - Turchia	14
MX - Messico	13
CA - Canada	12
BE - Belgio	9
IE - Irlanda	9
MA - Marocco	9
ID - Indonesia	7
IQ - Iraq	7
PK - Pakistan	7
AT - Austria	5
JP - Giappone	5
UZ - Uzbekistan	5
JO - Giordania	4
SN - Senegal	4
AE - Emirati Arabi Uniti	3
CH - Svizzera	3
CL - Cile	3
DZ - Algeria	3
PY - Paraguay	3
SA - Arabia Saudita	3
AR - Argentina	2
BO - Bolivia	2
CO - Colombia	2
CZ - Repubblica Ceca	2
EU - Europa	2
HN - Honduras	2
IR - Iran	2
KE - Kenya	2
UY - Uruguay	2
VE - Venezuela	2
A2 - ???statistics.table.value.countryCode.A2???	1
AG - Antigua e Barbuda	1
AO - Angola	1
AU - Australia	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BH - Bahrain	1
BS - Bahamas	1
CY - Cipro	1
DM - Dominica	1
DO - Repubblica Dominicana	1
HU - Ungheria	1
IL - Israele	1
JM - Giamaica	1
KH - Cambogia	1
LK - Sri Lanka	1
MD - Moldavia	1
MR - Mauritania	1
NZ - Nuova Zelanda	1
OM - Oman	1
PA - Panama	1
PT - Portogallo	1
QA - Qatar	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
ZA - Sudafrica	1
Totale	1.994

Nome	#
The cytoplasmic side of p53's oncosuppressive activities	254
A Pin1/mutant p53 axis promotes aggressiveness in breast cancer.	253
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer.	207
A Targeted Proteomics Approach for Screening Serum Biomarkers Observed in the Early Stage of Type I Endometrial Cancer	187
Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome	178
A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome	169
A novel mutation in MECOM affects MPL regulation in vitro and results in thrombocytopenia and bone marrow failure	135
The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer	133
ETV6-related thrombocytopenia: dominant negative effect of mutations as common pathogenic mechanism	131
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant	122
Ketorolac use in the emergency department in children: a systematic review and meta-analysis	122
A Multi-Omics Approach Revealed Common Dysregulated Pathways in Type One and Type Two Endometrial Cancers	120
The homoplasmic MT-TK m.8357T > C mtDNA variant as a cause of multiorgan mitochondrial disease	40
Totale	2.051

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	7	0	0	0	0	0	0	0	0	0	0	0	7
2021/2022	93	3	1	7	7	5	12	4	4	9	4	9	28
2022/2023	168	13	27	17	25	12	32	0	17	14	0	9	2
2023/2024	99	4	2	6	7	8	18	17	18	3	1	6	9
2024/2025	294	7	12	29	32	25	26	12	14	36	43	30	28
2025/2026	1.089	118	58	78	90	104	58	117	47	97	154	101	67
Totale													2.051

ArTS Archivio della ricerca di Trieste